Inhibition of hepatocyte growth factor/c-Met signalling abrogates joint destruction by suppressing monocyte migration in rheumatoid arthritis.

导出 LinkOut

翻译打印收藏纠错

第一作者： Masahiro,Hosonuma

第一单位： Division of Rheumatology, Department of Medicine, Showa University School of Medicine, Shinagawa.

作者： Masahiro,Hosonuma ^[1] ; Nobuhiro,Sakai ^[2] ; Hidekazu,Furuya ^[3] ; Yutaro,Kurotaki ^[4] ; Yurie,Sato ^[3] ; Kazuaki,Handa ^[4] ; Yusuke,Dodo ^[1] ; Koji,Ishikawa ^[3] ; Yumi,Tsubokura ^[4] ; Takako,Negishi-Koga ^[5] ; Mayumi,Tsuji ^[3] ; Tsuyoshi,Kasama ^[4] ; Yuji,Kiuchi ^[6] ; Masamichi,Takami ^[2] ; Takeo,Isozaki ^[3]

作者单位： Division of Rheumatology, Department of Medicine, Showa University School of Medicine, Shinagawa. ^[1] Division of Medical Pharmacology, Department of Pharmacology, Showa University School of Medicine, Shinagawa. ^[2] Department of Pharmacology, Showa University School of Dentistry, Shinagawa. ^[3] Parmacological Research Center, Showa University, Shinagawa. ^[4] Division of Community-Based Comprehensive Dentistry, Department of Special Needs Dentistry, School of Dentistry, Showa University, Ota. ^[5] Division of Dentistry for Persons with Disabilities, School of Dentistry, Showa University, Ota. ^[6] Department of Orthopaedic Surgery, Showa University School of Medicine, Shinagawa. ^[7] Division of Mucosal Barriology, International Research and Development Centre for Mucosal Vaccines, The Institute of Medical Science, The University of Tokyo, Minato, Tokyo, Japan. ^[8]

关键词 c-Met chemokines hepatocyte growth factor rheumatoid arthritis